Levonorgestrel-releasing intrauterine system linked to increased breast cancer risk
Exposure to the levonorgestrel-releasing intrauterine system, especially during the first few years, appears to contribute to a heightened risk of breast cancer among women with abnormal uterine bleeding, endometriosis, or leiomyomas, according to a retrospective study.
